Lorrain Daniel S.
Officer at CTNM
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jul 9, 2026
- Form 144 notices
- 13
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CTNMContineum Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CTNMRoutineJun 1, 2026 2026
Sold 4,170 shares at $13.16 ($55k)
Lorrain Daniel S., Chief Scientific Officer
10b5-1 planSold 2.9% of holdings ($1.9M position)139,372 shares left1x usual sizeFollows a Form 144Filing
- 2 Form 144 notice CTNMNoticeJun 30, 2026 +29 days
Filed to sell 28,826 shares ($432k)
Lorrain Daniel S., Officer
10b5-1 plan6.9x usual sizeFiling
- 3 Form 144 notice CTNMNoticeJul 1, 2026 +1 day
Filed to sell 9,520 shares ($156k)
Lorrain Daniel S., Officer
10b5-1 plan2.3x usual sizeFiling
- 4 Form 4 sale CTNMUnusualJul 1, 2026 same day
Sold 37,179 shares at $16.00 ($595k)
Lorrain Daniel S., Chief Scientific Officer
10b5-1 planSold 21.6% of holdings ($2.8M position)135,202 shares left8.9x usual sizeFollows a Form 144Filing
- 5 Form 4 sale CTNMRoutineJul 9, 2026 +8 days
Sold 1,040 shares at $16.00 ($17k)
Lorrain Daniel S., Chief Scientific Officer
10b5-1 planSold 0.8% of holdings ($2.2M position)135,202 shares left0.2x usual sizeFollows a Form 144Filing
- 6 Form 144 notice CTNMNoticeAug 3, 2026 +25 days
Filed to sell 9,520 shares ($147k)
Lorrain Daniel S., Officer
10b5-1 plan2.3x usual sizeFiling
- 7 Form 144 notice CTNMNoticeSep 1, 2026 +29 days
Filed to sell 9,520 shares ($155k)
Lorrain Daniel S., Officer
10b5-1 plan2.3x usual sizeFiling
- 8 Form 144 notice CTNMNoticeOct 1, 2026 +30 days
Filed to sell 4,170 shares ($56k)
Lorrain Daniel S., Officer
10b5-1 plan1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (27)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 1, 2026 | CTNM | Officer | Form 144 notice | 4,170 | $56k | Notice | SEC | |
| Sep 1, 2026 | Sep 1, 2026 | CTNM | Officer | Form 144 notice | 9,520 | $155k | Notice | SEC | |
| Aug 3, 2026 | Aug 3, 2026 | CTNM | Officer | Form 144 notice | 9,520 | $147k | Notice | SEC | |
| Jul 9, 2026 | Jul 10, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 1,040 | $17k | 0.8% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 37,179 | $595k | 21.6% | Unusual | SEC |
| Jul 1, 2026 | Jul 1, 2026 | CTNM | Officer | Form 144 notice | 9,520 | $156k | Notice | SEC | |
| Jun 30, 2026 | Jun 30, 2026 | CTNM | Officer | Form 144 notice | 28,826 | $432k | Notice | SEC | |
| Jun 1, 2026 | Jun 1, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $55k | 2.9% | Routine | SEC |
| Jun 1, 2026 | Jun 1, 2026 | CTNM | Officer | Form 144 notice | 4,170 | $56k | Notice | SEC | |
| May 1, 2026 | May 1, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $55k | 2.8% | Routine | SEC |
| May 1, 2026 | May 1, 2026 | CTNM | Officer | Form 144 notice | 4,170 | $53k | Notice | SEC | |
| Apr 6, 2026 | Apr 6, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $56k | 2.7% | Routine | SEC |
| Apr 6, 2026 | Apr 6, 2026 | CTNM | Officer | Form 144 notice | 914 | $12k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $63k | 2.7% | Routine | SEC |
| Feb 25, 2026 | Feb 26, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 8,124 | $130k | 4.9% | Routine | SEC |
| Feb 19, 2026 | Feb 20, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 100 | $2k | 0.1% | Routine | SEC |
| Feb 11, 2026 | Feb 13, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 400 | $6k | 0.3% | Routine | SEC |
| Feb 11, 2026 | Feb 11, 2026 | CTNM | Officer | Form 144 notice | 16,050 | $253k | Notice | SEC | |
| Feb 3, 2026 | Feb 5, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $62k | 2.6% | Routine | SEC |
| Feb 3, 2026 | Feb 3, 2026 | CTNM | Officer | Form 144 notice | 4,170 | $60k | Notice | SEC | |
| Jan 5, 2026 | Jan 6, 2026 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $44k | 2.5% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | CTNM | Officer | Form 144 notice | 4,170 | $47k | Notice | SEC | |
| Dec 23, 2025 | Dec 30, 2025 | CTNM | Chief Scientific Officer | Form 4 sale | 4,170 | $51k | 2.5% | Routine | SEC |
| Dec 23, 2025 | Dec 23, 2025 | CTNM | Officer | Form 144 notice | 4,170 | $51k | Notice | SEC | |
| Nov 25, 2024 | Nov 27, 2024 | CTNM | Chief Scientific Officer | Form 4 sale | 1,010 | $16k | 0.6% | Routine | SEC |
| Nov 18, 2024 | Nov 20, 2024 | CTNM | Chief Scientific Officer | Form 4 sale | 6,190 | $101k | 3.5% | Routine | SEC |
| Nov 18, 2024 | Nov 18, 2024 | CTNM | Officer | Form 144 notice | 26,370 | $454k | Notice | SEC |